Lisa M. Baumann Kreuziger, MD, MS

Publications

• A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry.

  (Abou-Ismail MY, Zhang C, Presson AP, Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Baumann Kreuziger L, Sridharan M, Go RS, McCrae KR, Upreti HV, Gangaraju R, Kocher NK, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson AD, Davis E, Evans MD, Mazepa M, Lim MY.) Blood Adv. 2024 Feb 13;8(3):620-623 PMID: 38100454 PMCID: PMC10838690 SCOPUS ID: 2-s2.0-85185406132 12/15/2023

• Primary Care Clinicians’ Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment

  (Groat D, Martin KA, Rosovsky RP, Sanfilippo KM, Gaddh M, Baumann Kreuziger L, Federici E, Woller SC.) Journal of Clinical Medicine. January 2024;13(1) SCOPUS ID: 2-s2.0-85181869901 01/01/2024

• Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry.

  (Lee Cervi A, Applegate D, Stevens SM, Woller SC, Baumann Kreuziger LM, Punchhalapalli K, Wang TF, Lecumberri R, Greco K, Bai Y, Bolger S, Fontyn S, Schulman S, Foster G, Douketis JD.) J Thromb Haemost. 2023 Dec;21(12):3581-3588 PMID: 37739038 SCOPUS ID: 2-s2.0-85174802544 09/23/2023

• American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing.

  (Middeldorp S, Nieuwlaat R, Baumann Kreuziger L, Coppens M, Houghton D, James AH, Lang E, Moll S, Myers T, Bhatt M, Chai-Adisaksopha C, Colunga-Lozano LE, Karam SG, Zhang Y, Wiercioch W, Schünemann HJ, Iorio A.) Blood Adv. 2023 Nov 28;7(22):7101-7138 PMID: 37195076 PMCID: PMC10709681 SCOPUS ID: 2-s2.0-85165403186 05/17/2023

• A 10-year single-institution retrospective review of treatment for acquired hemophilia A.

  (Wu JF, Malec LM, Pandit S, Abid H, Jha P, Baumann Kreuziger LM.) Haemophilia. 2023 Nov;29(6):1656-1660 PMID: 37694801 SCOPUS ID: 2-s2.0-85170657772 09/11/2023

• Comparison of Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations.

  (Gaddh M, Scott D, Wysokinski WE, McBane RD, Casanegra AI, Baumann Kreuziger L, Houghton DE.) TH Open. 2023 Oct;7(4):e303-e308 PMID: 38053618 PMCID: PMC10695705 12/06/2023

• Natural Language Processing tool accurately identifies acute venous thromboembolism.

  (Scott DM, Abud A, Amor M, Saemi A, Baumann Kreuziger L, Houghton D.) Thromb Res. 2023 Sep;229:252-254 PMID: 37595367 SCOPUS ID: 2-s2.0-85168319687 08/19/2023

• DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network.

  (Martin KA, Lancki N, Kreuziger LB, Li C, Eyster ME, Sanfilippo K, Woller SC, Rosovsky RP.) Thromb Res. 2023 Sep;229:146-148 PMID: 37454464 SCOPUS ID: 2-s2.0-85165295419 07/16/2023

• Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial.

  (Solomon SD, Lowenstein CJ, Bhatt AS, Peikert A, Vardeny O, Kosiborod MN, Berger JS, Reynolds HR, Mavromichalis S, Barytol A, Althouse AD, Luther JF, Leifer ES, Kindzelski AL, Cushman M, Gong MN, Kornblith LZ, Khatri P, Kim KS, Baumann Kreuziger L, Wahid L, Kirwan BA, Geraci MW, Neal MD, Hochman JS, ACTIV4a Investigators.) Circulation. 2023 Aug;148(5):381-390 PMID: 37356038 PMCID: PMC10373640 SCOPUS ID: 2-s2.0-85166387000 06/25/2023

• Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.

  (Berger JS, Neal MD, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Althouse AD, Lawler PR, McVerry BJ, Kim KS, Baumann Kreuziger L, Solomon SD, Kosiborod MN, Berry SM, Bochicchio GV, Contoli M, Farkouh ME, Froess JD, Gandotra S, Greenstein Y, Hade EM, Hanna N, Hudock K, Hyzy RC, Ibáñez Estéllez F, Iovine N, Khanna AK, Khatri P, Kirwan BA, Kutcher ME, Leifer E, Lim G, Lopes RD, Lopez-Sendon JL, Luther JF, Nigro Maia L, Quigley JG, Wahid L, Wilson JG, Zarychanski R, Kindzelski A, Geraci MW, Hochman JS, ACTIV-4a Investigators.) JAMA Netw Open. 2023 May 01;6(5):e2314428 PMID: 37227729 PMCID: PMC10214036 SCOPUS ID: 2-s2.0-85160458766 05/25/2023

• The crux of menopausal hormone therapy: dose, route, and age

  (Hobbs LM, Baumann Kreuziger LM.) Research and Practice in Thrombosis and Haemostasis. November 2023;7(8) SCOPUS ID: 2-s2.0-85179482574 11/01/2023

• Plasma tissue-type plasminogen activator is associated with lipoprotein(a) and clinical outcomes in hospitalized patients with COVID-19

  (Zhang Z, Dai W, Zhu W, Rodriguez M, Lund H, Xia Y, Chen Y, Rau M, Schneider EA, Graham MB, Jobe S, Wang D, Cui W, Wen R, Whiteheart SW, Wood JP, Silverstein R, Berger JS, Kreuziger LB, Barrett TJ, Zheng Z.) Research and Practice in Thrombosis and Haemostasis. August 2023;7(6) SCOPUS ID: 2-s2.0-85169507694 08/01/2023